The U.S. Meals and Drug Administration (FDA) has granted precedence evaluation to a supplemental biologics license software for first-line remedy with Enhertu...
The U.S. Meals and Drug Administration (FDA) granted quick monitor designation to the ATR inhibitor alnodesertib plus low-dose irinotecan for the remedy...
